LI Wuwu1,2, ZHANG Zunting1*
(1 Key Laboratory of the Ministry of Education for Medicinal Resources and Natural Pharmaceutical Chemistry, National Engineering Laboratory for Resource Development of Endangered Crude Drugs in Northwest of China, School of Chemistry and Chemical Engineering, Shaanxi Normal University, Xi′an 710119, Shaanxi, China;2 College of Chemistry & Chemical Engineering, Xianyang Normal University, Xianyang 712000, Shaanxi, China)
Abstract:
According to physiological activity structure combination strategy, 3, 3′-bisubstituted-2-oxindole skeleton and acrylate group were joined together, through the Morita-Baylis-Hilleman reaction. A series of 3, 3′-bisubstituted-2-oxindole derivatives(3a—3r) were synthesized with isatin (2,3-diketoindoline) and its derivatives as leading compounds. The structure of 3a—3r were characterized by 1H NMR, 13C NMR and MS or HRMS. Their anti-proliferative activities in vitro against human leukemia cells K562 and human prostate cancer cells PC-3 were evaluated by the standard MTT assay. The pharmacological activity results showed that this kind of compounds has anti-proliferative activity against human cancer cells K562 and PC-3, the anti-proliferative activity against K562 of 3j is the strongest, the anti-proliferative activity against Pc-3 of 3r is the strongest, their anti-proliferative activity are 2.85 and 4.24 times better than that in positive control group cisplatin, respectively.
KeyWords:
3, 3′-bisubstituted-2-oxindole; synthesis; antitumor activity